We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01401309
Recruitment Status : Completed
First Posted : July 25, 2011
Last Update Posted : February 21, 2014
Sponsor:
Information provided by (Responsible Party):
Southwestern Regional Medical Center

Brief Summary:
This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.

Condition or disease
Colon Cancer

Study Type : Observational
Actual Enrollment : 81 participants
Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Effects of Respiratory Gating on FDG/PET Detection of Hepatic Metastasis in Patients With Colon Cancer
Study Start Date : January 2011
Primary Completion Date : November 2011
Study Completion Date : March 2013



Primary Outcome Measures :
  1. Detecting [ Time Frame: Jan 2011 - Nov 2011 ]
    To exam if there is an improved sensitivity in detecting hepatic lesions using respiratory gating and if there is improvement in confidence defining lesions as benign or malignant



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with colon cancer
Criteria

Inclusion Criteria:

  • Patients with colon cancer
  • 18 years or older
  • Signed Informed Consent Form
  • Blood Glucose of 200 or less prior to scan

Exclusion Criteria:

  • Patients with known hepatic metastasis

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01401309


Locations
United States, Oklahoma
Cancer Treamtent Centers of America at Southwestern Regional Medical Center, Inc
Tulsa, Oklahoma, United States, 74133
Sponsors and Collaborators
Southwestern Regional Medical Center

Responsible Party: Southwestern Regional Medical Center
ClinicalTrials.gov Identifier: NCT01401309     History of Changes
Other Study ID Numbers: SRMC 10-07
First Posted: July 25, 2011    Key Record Dates
Last Update Posted: February 21, 2014
Last Verified: February 2014

Additional relevant MeSH terms:
Colonic Neoplasms
Colorectal Neoplasms
Intestinal Neoplasms
Gastrointestinal Neoplasms
Digestive System Neoplasms
Neoplasms by Site
Neoplasms
Digestive System Diseases
Gastrointestinal Diseases
Colonic Diseases
Intestinal Diseases